CompletedNot Applicable

EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

China38 participantsStarted 2018-12-20

Plain-language summary

the study evaluate the efficacy and safety of EUS-RFA using Habib EUS-RFA catheter with a prospective randomised trial in patients with inoperable PDAC.

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients in the age group 20 to 80 years * A cytological or histological diagnosis of inoperable PDAC based on multidisciplinary review of cross sectional imaging and cytology or histology results. * Patients who have been deemed unfit for surgical resection of the PDAC subjects who are fit for surgical resection but have declined surgery will also be considered for the study * PDAC patients presenting with jaundice to be considered after a successful biliary drainage * Patients ought to be fit enough to be considered for the study (ECOG performance status 0, 1 or 2) * Patients capable of giving informed consent Exclusion Criteria: * Inability to give informed consent * Pregnancy or breast feeding * ECOG performance status 3 or 4 * Life expectancy less than 3 months * Patients with distant metastases or malignant ascites

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in tumour size as measured on EUS and or CT

Timeframe: 60 days

Change in serum levels of Ca 19-9

Timeframe: 60 days

Trial details

NCT IDNCT03772756

SponsorFirst People's Hospital of Hangzhou

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-16

View on ClinicalTrials.gov More Pancreatic Adenocarcinoma Non-resectable trials

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.